During the past decade, US Associates in Research LLC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "US Associates in Research LLC" are "Chlamydia" (1 trials), "Covid19" (1 trials), "Gonorrhea" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials) and "Non-alcoholic Steatohepatitis (NASH)" (1 trials). Many other conditions were trialed in "US Associates in Research LLC" in a lesser frequency.

Most popular intervention types in "US Associates in Research LLC" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "CSL312" (1 trials), "EVO100" (1 trials), "Favipiravir" (1 trials) and "No Intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "US Associates in Research LLC" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "US Associates in Research LLC". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in US Associates in Research LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in US Associates in Research LLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".